PAIA
DGX icon

Park Avenue Institutional Advisers’s Quest Diagnostics DGX Stock Holding History

Park Avenue Institutional Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-903
Closed -$74K – 114
2016
Q2 		$74K Hold
903
– – 0.06% 338
2016
Q1 		$65K Sell
903
-34
-4% -$2.28K 0.06% 368
2015
Q4 		$67K Sell
937
-19
-2% -$1.28K 0.06% 358
2015
Q3 		$59K Sell
956
-18
-2% -$1.26K 0.05% 390
2015
Q2 		$71K Buy
+974
New +$71.9K 0.06% 359

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Park Avenue Institutional Advisers's DGX Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Quest Diagnostics (DGX) in Q3 2016, closing a stake of 903 shares — an estimated $74K sold.

Park Avenue Institutional Advisers first reported a position in DGX in Q2 2015 and held it in 5 quarters. The position peaked at $74K in Q2 2016. 559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Quest Diagnostics position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 903 Quest Diagnostics shares in Q3 2016, an estimated $74K.
  • Park Avenue Institutional Advisers first reported a position in Quest Diagnostics in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Quest Diagnostics position peaked at $74K in Q2 2016.
  • 559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.